Cuzick J., Szarewski A., Terry G., et al. Human papillomavirus testing in primary cervical screening. Lancet1995; 34: 1533-6.
2.
Organising Committee and Collaborators, Falun meeting.Breast cancer screening with mammography in women aged 40-49 years. International Journal of Cancer1996; 68: 693-9.
3.
Chen HH, Duffy SW, Tabar L., Day NEMarkov chain models for progression of breast cancer, part 2: prediction of outcomes for different screening regimes. Journal of Epidemiology and Biostatisitcs1987; 2: 25-35.
4.
Van Oortmarssen GJ, Habbema JDDuration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears. International Journal of Epidemiology1995; 24: 300-7.
5.
Kafadar K., Prorok PCA data-analytic approach for estimating lead time and screening benefit based on survival curves in randomized cancer screening trials. Statistics and Medicine1994; 13: 569-86.
6.
Torrance-Rynard VL, Walter SDEffects of dependent errors in the assessment of diagnostic test performance. Statistics and Medicine1997; 16: 2157-75.
7.
Chock C., Irwig L., Berry G., Glasziou P.Comparing dichotomous screening tests when individuals negative on both tests are not verified. Journal of Clinical Epidemiology1997; 50: 1211-7.
